Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Deals
T&L Biotechnology Secures RMB 100 Million in Series A Financing
January 6, 2025
Company
Drug
Yiling Pharmaceutical’s BIO-008 Receives NMPA Approval for Clinical Trials
January 6, 2025
Company
Drug
Hengrui Pharmaceuticals’ SHR8028 Receives NMPA Review for Dry Eye Treatment
January 6, 2025
Company
Deals
LBX Pharmacy Partners with Gilead Sciences to Enhance Disease Management in China
January 6, 2025
Company
Drug
Jiangsu Recbio’s ReCOV Vaccine Receives Emergency Use Authorization in Mongolia
January 6, 2025
Company
WuXi AppTec Reports 71.8% Revenue Growth in 2022 Financials
January 6, 2025
Company
Drug
Luye Pharma’s BA1102 Biosimilar to Xgeva Accepted for CDE Review
January 6, 2025
Company
Drug
Bayer’s Nubeqa Receives Additional NMPA Approval for mHSPC Treatment-Fineline Info & Tech
January 6, 2025
Company
Drug
NMPA Denies Market Approval for Hengrui’s Plinabulin in Chemotherapy-Induced Neutropenia
January 6, 2025
Company
Drug
SciClone Pharmaceuticals’ Vaborem Approved for Phase III Clinical Trial in China
January 6, 2025
Company
Drug
Janssen Withdraws Carvykti from UK Market Amid Manufacturing Concerns
January 6, 2025
Company
Deals
BeiGene Declines Option for Leap Therapeutics’ DKN-01 Development Rights in Asia
January 6, 2025
1
2
…
1,007
1,008
1,009
1,010
1,011
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?